Connecticut Bill to Reject Some FDA Restrictions on Terminal Patients Clears Committee 24-2
HARTFORD, Conn. (March 8, 2016) – A Connecticut bill that would set the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients passed out of an important joint committee Monday. A coalition of six representatives and senators introduced House Bill 5270 (HB5270)…